Oscar Health, Inc. OSCR
Regular-session close
After hours · Nov 13, 6:59 PM ET
- YTD
- +116.08%
- 1 year
- +122.58%
- Market cap
- 9.65B
- Revenue (ttm)
- 17.47B
- Profit margin
- 4.90%
- EPS (ttm)
- 2.25
- Shares out
- 275.51M
- P/E ratio
- 13.80
- Forward P/E
- 12.67
- YTD return
- +116.08%
- 1-year return
- +122.58%
- Volume
- 4.85M
- Avg volume
- 5.27M
- Open
- 32.03
- Previous close
- 31.94
- Day's range
- 29.82 – 32.40
- 52-week range
- 10.85 – 35.19
- Beta
- 2.49
- Analysts
- Hold
- Price target
- 37.00 (+19.2%)
- Earnings date
- Feb 9, 2027
5D -0.69 (-2.17%)
Key statistics
- Enterprise value
- 2.91B
- PEG ratio
- 0.00
- Price / sales
- 0.55
- Price / book
- 4.34
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 72.10%
- Free cash flow
- 1.73B
- Total cash
- 7.49B
- Total debt
- 481.73M
- Return on equity
- 52.62%
- Short % of float
- 6.57%
- 50-day average
- 32.02
- 200-day average
- 24.35
Fundamental scorecard
15 of 25 checks passed on OSCR’s reported financials
15of 25 checks passed
- Value 2 of 5
- Growth 4 of 5
- Profitability 4 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: hold
- Target (low)
- 27.00
- Target (mean)
- 37.00
- Target (high)
- 49.00
- Strong buy3
- Buy0
- Hold7
- Sell0
- Strong sell1
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate -1.09.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | -1.08 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | -0.14382 | 0.49 | +0.63 | +440.70% |
| Aug 6, 2026 | Jun 30, 2026 | 0.403 | 1.10 | +0.70 | +172.95% |
| May 6, 2026 | Mar 31, 2026 | 1.21 | 2.07 | +0.86 | +71.07% |
| Feb 10, 2026 | Dec 31, 2025 | -0.9214 | -1.24 | -0.32 | -34.58% |
| Nov 6, 2025 | Sep 30, 2025 | -0.55 | -0.53 | +0.02 | +3.64% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Piper Sandler | main | Overweight | Overweight |
| Oct 12, 2026 | UBS | main | Neutral | Neutral |
| Sep 18, 2026 | Raymond James | main | Outperform | Outperform |
| Sep 17, 2026 | B of A Securities | main | Underperform | Underperform |
| Sep 17, 2026 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Sep 17, 2026 | Barclays | main | Overweight | Overweight |
About Oscar Health, Inc.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- hioscar.com
News
Josh Kushner Bets Big on Elon Musk, More Than Doubles Thrive Capital Stake in SpaceX Stock in Q3
Best Growth Stocks to Buy for November 12th
HealthEx Partners with Oscar Insurance to Bring Members' Medical Records Into the Oscar App
Best Growth Stocks to Buy for November 10th
Obamacare Subsidies Lapsed. Here's Why Health Insurer Stocks Are Watching the New Congress. Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45
Oscar Health Q3 2026 Earnings Call Transcript Oscar Health Raises FY2026 Sales Guidance from $18.700B-$19.000B to $19.000B-$19.300B vs $18.732B Est
Oscar Health Q3 EPS $0.49 Beats $(0.20) Estimate, Sales $5.139B Beat $4.723B Estimate
UBS Maintains Neutral on Oscar Health, Raises Price Target to $36
Your note
Sign in to keep a note on OSCR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERTOLINI MARK T | Chief Executive Officer | Sale | Jun 29, 2026 | 7,751,570 |
| BLACKLEY RICHARD SCOTT | Chief Financial Officer | Sale | Sep 2, 2026 | 1,102,360 |
| BOPITIYA RANMALI WOODY | Officer | Sale | Dec 1, 2024 | 241,488 |
| BOYD JEFFERY H | Director | Stock Award(Grant) | Jun 3, 2025 | 705,673 |
| KUSHNER JOSHUA | Officer, Director and Beneficial Owner | Purchase | Nov 20, 2024 | 0 |
| LIANG JANET | Officer | Sale | Sep 2, 2026 | 248,697 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.47% | 20,587,428 | 639.34M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 4.73% | 13,035,486 | 404.82M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 4.59% | 12,643,617 | 392.65M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.00% | 11,029,424 | 342.52M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.84% | 10,579,437 | 328.54M | Jun 29, 2026 |
| FMR, LLC | 3.27% | 8,998,716 | 279.46M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.76% | 7,599,713 | 236.01M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.28% | 6,283,032 | 195.12M | Sep 29, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2.16% | 5,944,429 | 184.60M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.99% | 5,490,151 | 170.50M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.15% | 3,163,647 | 98.25M | Jun 29, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1.11% | 3,055,642 | 94.89M | Jun 29, 2026 |
